Financial Statements — NRSN
Balance Sheet
(in millions USD)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Cash & Equivalents | 0.67 | 1.21 | 7.09 | 4.35 |
| Total Current Assets | 1.56 | 1.62 | 7.56 | 11.10 |
| Property, Plant & Equipment | 0.06 | 0.08 | -- | -- |
| Total Non-current Assets | 0.13 | 0.22 | 0.31 | 0.35 |
| Total Assets | 1.68 | 1.84 | -- | -- |
| Total Current Liabilities | 2.20 | 3.51 | 3.01 | 0.74 |
| Total Non-current Liabilities* | 0.00 | 0.04 | 6.41 | 0.88 |
| Total Liabilities | 2.20 | 3.54 | -- | -- |
| Retained Earnings | (41.37) | (32.38) | (29.90) | (14.64) |
| Total Stockholder Equity | (0.52) | (1.70) | (1.54) | 9.84 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Gross Profit | -- | -- | 0.01 | -- |
| Research & Development | 2.50 | 3.45 | -- | -- |
| Selling, General & Admin | 2.19 | 2.57 | -- | -- |
| Total Operating Expenses* | -- | 6.37 | 7.13 | -- |
| Operating Income | (4.69) | (6.02) | (7.12) | (6.85) |
| Net Income | (4.71) | (6.26) | (9.11) | (6.20) |
| Basic EPS | (0.19) | (0.37) | (0.77) | (0.55) |
| Diluted EPS | (0.19) | (0.37) | (0.77) | (0.55) |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Operating Cash Flow | (4.00) | (5.75) | (4.08) | (4.29) |
| Capital Expenditures | 0.01 | 0.00 | -- | -- |
| Free Cash Flow* | (4.00) | (5.75) | -- | -- |
| Investing Cash Flow | (0.01) | 0.00 | 3.52 | (6.05) |
| Financing Cash Flow | 1.30 | 4.32 | 4.10 | 3.71 |
* Derived from reported values